Online voting and e-voting could become a larger part of the political
process around the world but only if the right technologies and
processes are implemented to ensure its security, according to a new
Atlantic Council study sponsored by McAfee now part of Intel Security.
The lively, funny and entertaining co-stars of NBC TODAY’s fourth hour
are putting down their wine glasses and joining WWE ®
as guest stars on Monday Night Raw ® on October
6 at 8PM ET/7PM CT on USA Network.
CommScope Holding Company, Inc., a global provider of connectivity and
essential infrastructure solutions for wireless, business enterprise and
residential broadband networks, plans to participate in a fireside chat
at Wells Fargo Technology, Media and Telecom Conference on Thursday,
November 13 at 1:55 p.m. ET.
Facebook Inc.'s (FB) new ads platform, Atlas, will help Facebook grow its share of the $50 billion display advertising market to 33%, or $34 billion, by 2016, according to a note issued Friday by Pacific Crest Securities' social media analyst, Evan Wilson.
today announced $18 million in grants to Houston health care facilities
to support cancer prevention and cardiovascular research, expand
pediatric care for children with autism and enhance pediatric liver
disease research and clinical services.
WEST PALM BEACH, FL --
Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Apco Oil & Gas International Inc. (“Apco”) (NasdaqCM:
APAGF) concerning the acquisition by Pluspetrol Resources Corporation.
Sobeys Inc. Launches Better Food Fund Supporting Access to Better Food Canada NewsWire
STELLARTON, NS , Oct.1, 2014 /CNW/ - Sobeys is proud to today unveil the Sobeys Inc. Better Food Fund, which aligns its community investment activities to the Company's mission of helping Canadians Eat Better, Feel Better and Do Better .
This Phase I trial will test the safety and tolerability of lirilumab (BMS-986015) in combination with elotuzumab (BMS-901608) in patients with multiple myeloma This new Phase I initiated by Bristol-Myers Squibb is the first combination trial of lirilumab in a hematological tumor type
MARSEILLE, France, Oct.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.